Philippe Haas
Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay.
Jaun F, Boesing M, Lüthi-Corridori G, Abig K, Bloch N, Giezendanner S, Grillmayr V, Haas P, Leuppi-Taegtmeyer A, Muser J, Räss A, Schuetz P, Brändle M, Leuppi J. Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay. Biomedicines 2023; 11
Apr 25, 2023Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay.
Apr 25, 2023Biomedicines 2023; 11
Jaun Fabienne, Boesing Maria, Lüthi-Corridori Giorgia, Abig Kristin, Bloch Nando, Giezendanner Stéphanie, Grillmayr Victoria, Haas Philippe, Leuppi-Taegtmeyer Anne Barbara, Muser Jürgen, Räss Andrea, Schuetz Philipp, Brändle Michael, Leuppi Joerg Daniel
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Boesing M, Abig K, Brändle M, Brutsche M, Burri E, Frye B, Giezendanner S, Grutters J, Haas P, Heisler J, Jaun F, Leuppi-Taegtmeyer A, Lüthi-Corridori G, Müller-Quernheim J, Nüesch R, Pohl W, Rassouli F, Leuppi J. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. Trials 2022; 23:790.
Sep 20, 2022Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Sep 20, 2022Trials 2022; 23:790
Boesing Maria, Abig Kristin, Brändle Michael, Brutsche Martin, Burri Emanuel, Frye BjöC, Giezendanner Stéphanie, Grutters Jan C, Haas Philippe, Heisler Justian, Jaun Fabienne, Leuppi-Taegtmeyer Anne Barbara, Lüthi-Corridori Giorgia, Müller-Quernheim Joachim, Nüesch Reto, Pohl Wolfgang, Rassouli Frank, Leuppi Jörg D
High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.
Jaun F, Boesing M, Lüthi-Corridori G, Abig K, Makhdoomi A, Bloch N, Lins C, Raess A, Grillmayr V, Haas P, Schuetz P, Gabutti L, Muser J, Leuppi-Taegtmeyer A, Giezendanner S, Brändle M, Leuppi J. High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial. Trials 2022; 23:114.
Feb 4, 2022High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.
Feb 4, 2022Trials 2022; 23:114
Jaun Fabienne, Boesing Maria, Lüthi-Corridori Giorgia, Abig Kristin, Makhdoomi Anja, Bloch Nando, Lins Christina, Raess Andrea, Grillmayr Victoria, Haas Philippe, Schuetz Philipp, Gabutti Luca, Muser Jürgen, Leuppi-Taegtmeyer Anne Barbara, Giezendanner Stéphanie, Brändle Michael, Leuppi Jörg D
Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Bolli M, Sauter G, Heberer M, Harder F, Gambazzi F, Mirlacher M, Haas P, Dalquen P, Guller U, Adamina M, Kocher T, Spagnoli G. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Ann Surg 2002; 236:785-93; discussion 793.
Dec 1, 2002Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma
Dec 1, 2002Ann Surg 2002; 236:785-93; discussion 793
Bolli Martin, Sauter Guido, Heberer Michael, Harder Felix, Gambazzi Franco, Mirlacher Martina, Haas Philippe, Dalquen Peter, Guller Ulrich, Adamina Michel, Kocher Thomas, Spagnoli Giulio C